ImmunityBio commands a premium valuation on the promise of Anktiva, a chemo-free immunotherapy platform showing early ...

Biopharma & Cigalah are two of the largest pharmaceutical commercial distributors in the Middle East and North Africa (MENA)ImmunityBio established a wholly owned subsidiary in the Kingdom of Saudi ...

So normally the way we give CAR-T is that we take out the T-cells from patients, then we engineer them to attack them myeloma, and then we give them back to them. But that takes time because ...

As of January 22, 2026, the study has enrolled 23 patients with recurrent or progressive GBM who progressed following standard-of-care therapy, including surgery, radiation, and temozolomide-based ...

Nonresponse to bridging therapy and high lymphocyte count were predictive of parkinsonism and nonrelapse mortality (NRM) after treatment with ciltacabtagene autoleucel (cilta-cel; Carvykti) in ...

“Many confounding factors in real life—including lifestyle, UV exposure, occupational hazards, and immune status—can ...

Dread Central rarely covers comic books, but Absolute Batman demands attention. Its unapologetic brutality is smashing DC sales records and leaving Marvel scrambling. Things kicked off with Black Mask ...

This week should really be dubbed Absolute Universe Week at DC Comics. As a result of a few delays here and there, we will have four Absolute titles out on Wednesday, Absolute Batman #16 by Scott ...

Hone Health reports that chronic inflammation is a key factor in heart disease risk often overlooked in standard health screenings.

Public health recommendations suggest individuals can resume normal activities 5 days after symptom cessation. However, our study finds that full recovery can take longer, indicating that delayed ...

Monoclonal B-cell lymphocytosis (MBL) is when you have a high number of identical B cells, under 5,000 per microliter, for at least 3 months. It usually causes no symptoms or need for active treatment ...